Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | type A flavoprotein, putative | 0.0023 | 0 | 0.5 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.006 | 0.3033 | 0.5 |
Chlamydia trachomatis | sulfite reductase | 0.0037 | 0.1154 | 0.5 |
Brugia malayi | FAD binding domain containing protein | 0.006 | 0.3033 | 0.3033 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0053 | 0.2474 | 0.5 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.006 | 0.3033 | 0.3033 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.006 | 0.3033 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.003 | 0.0558 | 0.5 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.006 | 0.3033 | 1 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.006 | 0.3033 | 1 |
Treponema pallidum | flavodoxin | 0.0023 | 0 | 0.5 |
Schistosoma mansoni | cytochrome P450 reductase | 0.006 | 0.3033 | 1 |
Leishmania major | p450 reductase, putative | 0.006 | 0.3033 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 1 | 1 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.003 | 0.0596 | 0.0151 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.006 | 0.3033 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0023 | 0 | 0.5 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.006 | 0.3033 | 1 |
Giardia lamblia | Hypothetical protein | 0.0053 | 0.2474 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.006 | 0.3033 | 1 |
Brugia malayi | flavodoxin family protein | 0.006 | 0.3033 | 0.3033 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.006 | 0.3033 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 1 | 1 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.006 | 0.3033 | 1 |
Plasmodium vivax | flavodoxin domain containing protein | 0.0053 | 0.2474 | 0.8159 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.003 | 0.0558 | 0.5 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.006 | 0.3033 | 1 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.006 | 0.3033 | 1 |
Trichomonas vaginalis | sulfite reductase, putative | 0.006 | 0.3033 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.3033 | 0.3033 |
Leishmania major | cytochrome P450 reductase, putative | 0.0053 | 0.2474 | 0.8159 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0053 | 0.2474 | 0.8159 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0023 | 0 | 0.5 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0023 | 0 | 0.5 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0037 | 0.1154 | 0.1154 |
Trypanosoma cruzi | p450 reductase, putative | 0.006 | 0.3033 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0023 | 0 | 0.5 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0037 | 0.1154 | 0.2407 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.006 | 0.3033 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0037 | 0.1154 | 0.1154 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.006 | 0.3033 | 1 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.006 | 0.3033 | 1 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.006 | 0.3033 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.3323 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.